Premier Alternatives

OxSonics Therapeutics

Oxford, United Kingdom · Founded 2013 · Privately Held (backing)

Operator of a therapeutics platform intended to develop an anti-cancer therapy to improve the delivery of agents to tumors by disrupting their structure. OxSonics Therapeutics is based in Oxford, United Kingdom and was founded in 2013. Its last reported valuation was $34.6 million in Jul 2020. It has raised $30.2 million.

Last reported valuation
$34.6M
Oct 2026
Priced at
—
Total raised
$30.2M
Last round
—

OxSonics Therapeutics key facts

as of Oct 2026
  • Operator of a therapeutics platform intended to develop an anti-cancer therapy to improve the delivery of agents to tumors by disrupting their structure.
  • OxSonics Therapeutics is valued at approximately $34.6M as of Oct 2026 (last reported valuation).
  • It has raised $30.2M; the latest was Later Stage VC in Oct 2025.
  • Notable investors include Innovate UK, University of Oxford, Perivoli Innovations, Anjost Investment, Winton Ventures — 10 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$34.6M

OxSonics Therapeutics's last reported valuation, Jul 2020. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of OxSonics Therapeutics with a free account
  • ·Watch OxSonics Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

OxSonics Therapeutics funding rounds

No rounds on record

No funding rounds for OxSonics Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

OxSonics Therapeutics valuation

OxSonics Therapeutics's last reported valuation was $34.6 million in Jul 2020. No priced round, secondary trade or fund mark has surfaced since.

OxSonics Therapeutics investors

10 investors are on record for OxSonics Therapeutics, including Innovate UK, University of Oxford, Perivoli Innovations and Anjost Investment.

About OxSonics Therapeutics

Operator of a therapeutics platform intended to develop an anti-cancer therapy to improve the delivery of agents to tumors by disrupting their structure. The company's platform combines particles that are co-administered independently with a drug and actively manages the delivery of oncology drugs into solid tumors, and requires no drug reformulation, enabling healthcare providers to create a localized pumping effect that increases the delivery and penetration of the therapeutics throughout the tumor.

Sector
Healthcare
HQ
Oxford, United Kingdom
Founded
2013
Employees
15
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.